Compound ID | 991
Class: Aminocoumarin
| Spectrum of activity: | Gram-positive |
| Details of activity: | Inhibitor of topoismerase, tested for treatment of HIV-1 and MDR S.aureus infection |
| Combined with other compounds: | Tested in combination with ciprofloxacin for the treatment of S.aures infections, no synergistic effect observed. |
| Propensity to select resistant mutants: | Coumermycin resistant mutants could be selected in vitro in 15 S.aureus strains tested in |
| Description: | Grunberg, E., R. Cleeland, and E. Titsworth. "Further observations on chemotherapeutic activity of coumermycin A1. I. Activity against Neisseria meningitidis type A and meningopneumonitis." Antimicrobial agents and chemotherapy 6 (1966): 397. |
| Year first mentioned: | 1966 |
| Development status: | Active |
| Reason dropped: | Weak bacteriocidal activity at high concentration despite reasonable bacteriostatic activity at lower concentrations. |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/54675768 |
| Guide to Pharmacology: | coumamycin |
| Citations: |
|